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Bacterial cell wall peptidoglycan is essential, maintaining both cel-
lular integrity and morphology, in the face of internal turgor pres-
sure. Peptidoglycan synthesis is important, as it is targeted by cell
wall antibiotics, including methicillin and vancomycin. Here, we
have used the major human pathogen Staphylococcus aureus to
elucidate both the cell wall dynamic processes essential for growth
(life) and the bactericidal effects of cell wall antibiotics (death)
based on the principle of coordinated peptidoglycan synthesis and
hydrolysis. The death of S. aureus due to depletion of the essen-
tial, two-component and positive regulatory system for peptido-
glycan hydrolase activity (WalKR) is prevented by addition of
otherwise bactericidal cell wall antibiotics, resulting in stasis. In
contrast, cell wall antibiotics kill via the activity of peptidoglycan
hydrolases in the absence of concomitant synthesis. Both methicil-
lin and vancomycin treatment lead to the appearance of perforat-
ing holes throughout the cell wall due to peptidoglycan
hydrolases. Methicillin alone also results in plasmolysis and mis-
shapen septa with the involvement of the major peptidoglycan
hydrolase Atl, a process that is inhibited by vancomycin. The bacte-
ricidal effect of vancomycin involves the peptidoglycan hydrolase
SagB. In the presence of cell wall antibiotics, the inhibition of pep-
tidoglycan hydrolase activity using the inhibitor complestatin
results in reduced killing, while, conversely, the deregulation of
hydrolase activity via loss of wall teichoic acids increases the death
rate. For S. aureus, the independent regulation of cell wall synthe-
sis and hydrolysis can lead to cell growth, death, or stasis, with
implications for the development of new control regimes for this
important pathogen.
peptidoglycan j antibiotics j cell wall j vancomycin j methicillin
How bacteria grow and divide is a fundamental question inmicrobiology, where many of the essential processes
involved are the targets of clinically important antibiotics. The
cell wall is crucial for bacterial survival, forming the interface
between the external and internal environments and maintain-
ing internal turgor pressure (1, 2). The major cell wall struc-
tural component is peptidoglycan (PG), a polymer of glycan
strands and peptide cross-links (3–5), the synthesis of which is
the target of antibiotics including β-lactams and glycopeptides
(6). These cell wall antibiotics inhibit the final stages of PG syn-
thesis where building blocks are incorporated into the existing
structure via the action of penicillin-binding proteins (PBPs)
(6). Several mechanisms linking the action of antibiotics to the
inhibition of essential processes in cell wall growth and division
have been suggested, including lytic and nonlytic death, oxida-
tive stress, and futile PG synthesis (7–12).
As a single macromolecule that surrounds the cell, PG can
increase in surface area to permit growth and division while
maintaining cellular integrity. It has been proposed that areal
PG growth occurs as a consequence of both synthesis and
hydrolysis (4, 13, 14), with new material being covalently bound
to the existing macrostructure and hydrolysis of existing bonds
allowing expansion. This leads to a simple set of hypotheses for
growth but also makes predictions as to the effects of inhibition
of PG homeostasis activities, including cell wall antibiotics
(Fig. 1A). The lack of either PG synthesis or hydrolysis will
result in cell death because of the continued activity of the
other, but the loss of both will lead to stasis.
Staphylococcus aureus is a major human antimicrobial-resistant
pathogen. As a spheroid cell with a simple growth and division
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cycle, it forms an excellent subject to demonstrate the basic princi-
ples underlying growth, division, and the action of antibiotics.
Many organisms have multiple PBPs, but S. aureus has only four,
of which PBP1 and PBP2 are essential for growth and division
(15–19). S. aureus also has many PG hydrolases (PGHs), including
SagB, which is involved in cell growth (20, 21). The bifunctional
Atl is involved in generalized cell lysis and cell separation after
septation and contains both amidase and glucosaminidase
domains (22, 23). PGHs often show functional redundancy with
several enzymes involved in the same process (20, 24). In
S. aureus, no individual PGH alone has been shown to be required
for either growth or division, but multiple PGHs are positively reg-
ulated by an essential two-component system, WalKR (25–27),
further suggesting that their collective activity is required.
Recently, using atomic force microscopy (AFM), we have
revealed that the molecular architecture of the PG is that of an
expanded hydrogel whose mature external surface is a porous
open network but with an interior surface characterized by a
much smoother and denser mesh of PG material (28). This pro-
vides an architectural framework from which to begin to eluci-
date the roles of PG synthesis and hydrolysis. Here, we have
taken an integrated approach to determine the role of PG
homeostasis in S. aureus growth, division, and the bactericidal
action of cell wall antibiotics.
Results
Role of PGHs in Growth and the Action of Antibiotics. S. aureus
has many putative PGHs, mostly of unknown function (20, 24,
29, 30), many of which are positively regulated by an essential
two-component system, WalKR (25–27). The loss of WalKR
results in growth inhibition and cell morphology defects and
Fig. 1. The role of regulation of PG hydrolases (PGHs) by WalKR in life and death. (A) Predictive model for how cell wall homeostasis governs bacterial
life and death. Both cell wall synthesis and hydrolysis are required for growth, loss of either results in death, or both, cell stasis. (B–H) Effect of 10 × mini-
mum inhibitory concentration (MIC) vancomycin for 3 h on conditional lethal strain S. aureus Pspac-walKR (without inducer; WalKR OFF) compared to the
control (with inducer; WalKR ON). (B) CFU relative to T = 0; after t test with Welch's correction: P (WalKR OFF  WalKR OFF + vancomycin, **) = 6.9 ×
103. (C and D) PG synthesis and transpeptidase activity measured by 14C-GlcNAc and Atto 488 dipeptide (53) incorporation, normalized against WalKR
ON. (E) Transmission electron microscopy (TEM) (scale bars, 300 nm). (F) Quantification of bacterial phenotypes (SI Appendix, Fig. S2; dark green: no sep-
tum, mid-green: incomplete septum, light green: complete septum, and yellow: growth defects). For samples shown, the number of individual cells quan-
tified was n > 300. (G) AFM topographic images of sacculi (scale bars, 150, 300, and 300 nm; data scales [DS], 85, 200, and 85 nm, respectively, from Left
to Right). (i) Insets show sacculus external architecture from Left to Right, (WalKR ON) from dashed box in panel G, (WalKR OFF) from SI Appendix,
Fig. S2E, (WalKR OFF+Van) from SI Appendix, Fig. S2D, respectively (scale bars, 50 nm; DS, 30, 52, and 32 nm, respectively, from Left to Right; images
were analyzed with NanoscopeAnalysis from Bruker using the default color scale). (H) Thickness distribution values for sacculi with SD (n = 5). For sample
size and data reproducibility, see Materials and Methods.
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absence of lysis in the presence of penicillin (26, 31). We first
verified the essentiality of WalKR using a conditional S. aureus
strain (Pspac-walKR) (32), where depletion of WalKR via
removal of the inducer isopropyl β-D-thiogalactopyranoside
(IPTG) led to >95% cell death within 3 h (Fig. 1B and SI
Appendix, Fig. S1 A and B). Using the Pspac-walKR strain and
growth in the presence, or absence, of IPTG for 3 h, the role of
WalKR was determined in cell wall dynamics (Fig. 1). We
observed that death is concomitant with continued PG synthesis
as measured by continued transglycosylase (14C-GlcNAc incor-
poration; Fig. 1C) and transpeptidase (Atto488 dipeptide incor-
poration; Fig. 1D) activities. Electron microscopy (EM) and
AFM revealed this is associated with a thickening of the cell
wall and aberrant septum formation (Fig. 1 E–H and SI
Appendix, Fig. S2). We have recently shown that S. aureus PG
has surface pores that do not penetrate the full thickness of the
PG (28). The depletion of WalKR led to the maintenance of the
pores, but they spanned a smaller fraction of the cell wall thick-
ness (SI Appendix, Fig. S2 H–M). These data support the model
whereby lack of processing by PGH leads to aberrant cell walls
that do not permit growth and division, potentially contributing
to cell death (Fig. 1A). We next tested whether prevention of PG
synthesis in the absence of PGH activity would lead to stasis and
rescue bacterial viability, as suggested by the model (Fig. 1A).
Cell wall antibiotics, such as methicillin (a β-lactam) and vanco-
mycin (a glycopeptide), are well-established inhibitors of PG syn-
thesis. Vancomycin addition for 3 h led to stasis of the walKR-
depleted cells, with significant reduction in cell death (Fig. 1B; P
= 6.9 × 103), coincident with the inhibition of PG synthesis and
lack of cell wall thickening (Fig. 1 C–H and SI Appendix, Fig.
S2), as predicted (Fig. 1A). A significant reduction in cell death
in walKR-depleted cells also occurred with the addition of methi-
cillin (SI Appendix, Fig. S1D; P = 6.3 × 103), although this is
only apparent at 3 h after antibiotic addition. That is, when both
PG synthesis and hydrolysis are inhibited, bacterial cell death is
avoided (stasis). Previously, it has been shown that the constitu-
tive expression of several PGH can complement the growth
defect due to loss of WalKR, including ScaD (SsaA) (26). The
scaD gene was chosen as it is regulated by WalKR (26) and
sagB, as this is a major PGH (20) that has not been shown to be
WalKR transcriptionally controlled. Notably, although constitu-
tive expression of either PGH could complement the growth
defect due to loss of WalKR, neither reversed the cell wall anti-
biotic stasis phenomenon, suggesting that multiple enzymes act
collectively in antibiotic-associated cell death (SI Appendix, Fig.
S1 E–H).
Effect of Cell Wall Antibiotics on Cellular Morphology. The simple
model for growth (Fig. 1A) predicts that bactericidal antibiotics
kill because of the inhibition of PG synthesis only when growth-
associated PGH activity is present. To explore the cellular and
molecular mechanisms involved, we characterized the impact of
cell wall synthesis inhibiting antibiotics on morphology.
Treatment with vancomycin, methicillin, or a combination of
both antibiotics led to 93 6 5, 97 6 2, and 92 6 4% death after
6 h, respectively (Fig. 2A). Both antibiotics led to a significant
increase in cell volume after 60 min treatment (Fig. 2B; P =
5.835 × 1036 [methicillin] and P = 3.262 × 1038 [vancomy-
cin]), and this was not due to PG synthesis as, within 15 min,
the incorporation of D-amino acids into PG was reduced to
basal levels for both treatments (Fig. 2C). A similar inhibition
of N-acetyl glucosamine incorporation into insoluble material
was found for vancomycin, while residual incorporation was
found for methicillin (Fig. 2D). The addition of methicillin led
to swollen “bulbous” septa with apparent plasmolysis, where
the membrane retracted away from the cell wall (Fig. 2 E and F
and SI Appendix, Fig. S3A). These bulbous septa have been
observed previously and have been associated with the killing
mechanism of β-lactams (8). Conversely, vancomycin or a com-
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Fig. 2. The bactericidal action of cell wall antibiotics. Effect of 10 × MIC methicillin and/or vancomycin on S. aureus SH1000. (A) Survival of bacterial cells
after addition of antibiotic(s). (B) Cell volume as measured by structured illumination microscopy (SIM) after N-hydroxysuccinimide(NHS)-ester AlexaFluor
405 labeling. After t test with Welch's correction: P (control  methicillin 60 min, ****) = 5.835 × 1036, P (control  vancomycin 60 min, ****) = 3.262 ×
1038. For each sample, n > 100. (C and D) PG synthesis and transpeptidase activity measured by Atto 488 dipeptide and 14C-GlcNAc incorporation. (E)
TEM. (scale bars, 300 nm). (F) Quantification of bacterial phenotypes (SI Appendix, Fig. S3; dark green: no septum, mid-green: incomplete septum, light
green: complete septum, and orange: plasmolysis). For samples shown, the number of individual cells quantified was n > 300. (G) Effect of 5 × MIC com-
plestatin on S. aureus SH1000 survival rate after 6 h, treated with methicillin or vancomycin. CFU relative to T = 0. After t test with Welch's correction: P
(methicillin  methicillin + complestatin, *) = 3.45 × 102, P (vancomycin  vancomycin + complestatin, *) = 4.01 × 102. For sample size and data repro-
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alterations in the septa (Fig. 2 E and F). Pulse-chase PG label-
ing and superresolution fluorescence microscopy showed that
the addition of either antibiotic prevents subsequent cell divi-
sion (SI Appendix, Fig. S3B). Cryoelectron microscopy (cryo-
EM) tomography independently confirmed the bulbous septa
and plasmolysis effects of methicillin, with membrane invagina-
tion and blebs observed (SI Appendix, Fig. S4 and Movies
S1–S5). Bulbous septa were still present when growth inhibitory
concentrations of cerulenin (33) or moenomycin (34) were
used in the presence of methicillin, suggesting that this pheno-
type is not due to continued lipid production or glycan synthe-
sis via PBP2, respectively (SI Appendix, Fig. S5 A–F). The role
of teichoic acids was determined by analysis of tarO and ltaS
mutants that are missing wall teichoic or lipoteichoic acids,
respectively (35, 36). The loss of either of these polymers did
not reduce the plasmolysis phenotype after methicillin treat-
ment (SI Appendix, Fig. S5 G–L). In both mutants the plasmol-
ysis was methicillin specific, as it was not seen in the presence
of vancomycin or when cells were treated with both antibiotics
(SI Appendix, Fig. S5 G–L). We suggest that the plasmolysis
occurs because of lesions in the cell wall that allow an explosive
release of turgor, the release of cell contents, and the pulling
away of the membrane from the cell wall. In the presence of
methicillin, PGH activity leads to a presumptive cell scission
without the synthesis of a complete septum. This in turn leads
to loss of turgor around the cell emanating from this point of
weakness. The observed effects were not methicillin specific, as
treatment with oxacillin also resulted in cell death, volume
increase, and bulbous septa, nor strain specific, as NewHG (37)
treated with vancomycin or methicillin and COL (38) with van-
comycin gave the same responses as SH1000 (SI Appendix, Fig.
S6). Thus, β-lactams and vancomycin have different effects on
cell morphology, suggesting that they might elicit alternative
bactericidal mechanisms.
Effect of Cell Wall Antibiotics on PG Architecture. The model (Fig.
1A) predicts that it is continued PGH activity that leads to cell
death in the presence of antibiotics, but what changes in the
cell wall (e.g., general thinning, catastrophic failure etc.) is
unclear. We utilized our recently developed AFM approach
(28) to explore this further (Fig. 3 A and B). During the first 60
min after the addition of antibiotics, there was only a small
reduction in thickness of the cell walls suggesting that overall
lysis has not occurred (control = 21.19 nm, methicillin = 14.71
nm, and vancomycin = 16.04 nm) (Fig. 3B; P = 5.5 × 106
[methicillin] and P = 3.4 × 104 [vancomycin]). However, this
was accompanied by dramatic changes to PG architecture at its
inner surface (Fig. 3A). In contrast to healthy cells, which have
a continuous fine mesh architecture characterized by a pore
size of less than 10 nm (28), we observed the appearance of a
significant number of holes in the fine mesh of the PG that pen-
etrated the entire cell wall thickness (Fig. 3 A and C–E and SI
Appendix, Fig. S7; P = 4.3 × 103 [methicillin] and P = 1.5 ×
103 [vancomycin]), which are inconsistent with maintenance of
turgor (28). The mesh architecture surrounding the holes
appeared identical to that in untreated cells (see black and
white arrows in Fig. 3A), implying that the holes are nucleated,
via PGH activity, within the existing PG mesh architecture.
After 120 min, cells are dying likely through the combination of
perforating holes and reduced cell wall thickness (SI Appendix,
Fig. S7 G and H). The effect of β-lactams was corroborated by
treating the cells with oxacillin (SI Appendix, Fig. S7I). It
appears that PGH activity without synthesis leads to the forma-
tion of a large number of wall-spanning holes which compro-
mise cell viability.
To test if the action of cell wall antibiotics leads to changes in
PG architecture in other species, we studied the rod-shaped,
gram-positive bacterium Bacillus subtilis. B. subtilis has multiple
PGHs (39) and a PG architecture similar to that in S. aureus,
exhibiting a tight mesh at the inside of the wall with the outside
having large deep pores (28). Here, methicillin led to rapid
death but without an increase in cell volume (SI Appendix, Fig.
S8). Within 30 min, significant changes to B. subtilis PG archi-
tecture had occurred, with a large number of wall-spanning
holes appearing at the inside surface of the wall as in S. aureus
(SI Appendix, Fig. S8), establishing a likely common overarch-
ing mechanism for the action of cell wall antibiotics.
To further explore the model outlined in Fig. 1A, we looked
for an alternative approach for interfering with PGH activity.
Recently, a novel antibiotic, complestatin, has been described
that binds to the cell wall and inhibits PGHs (40). While the
addition of complestatin alone had some bactericidal activity,
its coadministration with methicillin or vancomycin led to a sig-
nificant reduction in bacterial killing by those antibiotics (Fig.
2G and SI Appendix, Fig. S9A). Thus, the loss of the PG synthe-
sis leading to cell death, by the action of cell wall antibiotics,
can be commuted to stasis via the inhibition of PGH, in agree-
ment with the model (Fig. 1A).
Differential Antibiotic Action Reveals Two Modes of Bactericidal
Activity. Methicillin and vancomycin both kill S. aureus, associ-
ated with a cell volume increase and the appearance of wall-
spanning holes in the PG. However, methicillin alone leads to
plasmolysis and a reduction in cells with complete or incom-
plete septa. Vancomycin treatment stops cell cycle progression
as soon as it is added. Simultaneous addition of vancomycin
and methicillin (or oxacillin) led to an outcome identical to van-
comycin alone (Fig. 2 A and F and SI Appendix, Figs. S5 and
S6). Also, vancomycin inhibits Triton X-100–induced cell lysis
in the presence or absence of methicillin (SI Appendix, Fig.
S9B). This suggested an underlying, common bactericidal
mechanism between the antibiotics overlayed by another
methicillin-dependent process that is inhibited by vancomycin.
This second killing mode may require PGHs that are also
involved in Triton X-100–induced cell lysis. Vancomycin directly
inhibits the activity of Atl, the major PGH, which is also
involved in lysis and septal scission (23, 41, 42). The loss of Atl
led to a reduction in the rate of killing by methicillin but not
vancomycin, with the methicillin-associated appearance of plas-
molysis, cell swelling, and the loss of cells with complete and
incomplete septa (Fig. 4 A and B and SI Appendix, Fig. S9
C–E). After 60 min of methicillin treatment, the cell wall of atl
was thicker than SH1000 (SI Appendix, Fig. S7J). Also, in the
atl mutant, wall-spanning holes appeared with greatly reduced
area, although at the same frequency in the presence of methi-
cillin compared to its parent (Fig. 4 C–E).
Vancomycin treatment leads to wall-spanning holes appearing
within the fine mesh at the inside of the sacculus, where those
PGHs with membrane-spanning tethers are situated. SagB is a
major glucosaminidase, membrane anchored, with a pleiotropic
role in physiology and growth (20, 21). A sagB mutation resulted
in an increase of survival after vancomycin but not methicillin
treatment compared to SH1000 (Fig. 4A and SI Appendix, Fig.
S9F), although there was a reduction in cell swelling in the pres-
ence of methicillin when compared to the wild type (Fig. 4B).
This rules out simple cell expansion and bursting as the bacteri-
cidal mechanism. After 60 min treatment with either methicillin
or vancomycin, the isolated cell wall of sagB was thicker than the
wild type (SI Appendix, Fig. S7J; P = 0.0016 and P = 0.0003,
respectively). Treated with methicillin, the sagB mutant devel-
oped the same number and area of wall-spanning holes as
SH1000, while vancomycin resulted in both fewer and smaller
holes (Fig. 4 C–E; P = 1.24 × 102). These results demonstrate
two modes of cell death associated with growth and division
that, respectively, involve the major PGHs, SagB, and Atl.
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Effect of PGH Deregulation on the Bactericidal Action of
Antibiotics. As the diminution of PGH activity led to a reduced
bactericidal rate for cell wall antibiotics (Figs. 2G and 4), their
deregulation was explored as a mode of enhancing killing. It
has been previously established that PGH activity is negatively
regulated by wall teichoic acids (WTAs), which are covalently
bound to the PG. The loss of WTAs in a tarO mutant (43)
increases cell lysis because of the deregulation of endogenous
PGH activity (44, 45). Here, we found that a tarO mutant dies
more rapidly on treatment with either methicillin or vancomy-
cin (SI Appendix, Fig. S10A), consistent with deregulated PGH
activity. In fact, no viable tarO cells were detectable after 12
and 24 h exposure (>107-fold colony-forming unit [CFU]
reduction, methicillin, or vancomycin, respectively), thereby
removing persisters that can clinically lead to the breakdown of
antibiotic treatment regimes (46). WTA levels can be reduced
by the addition of synthesis inhibitors such as tarocin A1, which
also resensitizes methicillin-resistant S. aureus strains to
β-lactams (47–49). To test if tarocin can increase the killing
activity of methicillin in vivo, independent of effects on antibi-
otic resistance, these compounds were coadministered using
the established murine sepsis model of infection with S. aureus
NewHG (a methicillin-sensitive strain) (SI Appendix, Fig. S10
B–D). Indeed, tarocin had no effect on disease in this model,
but its addition increased methicillin efficacy, with a signifi-
cant reduction in the bacterial burden in the liver (SI
Appendix, Fig. S10D). Thus, tarocin, as an adjunct therapy,
increases methicillin effectiveness, potentially reducing the
length of treatment for both antibiotic-resistant and sensi-
tive strains.
Fig. 3. The effect of cell wall antibiotics on PG architecture. (A) AFM images of the internal surface of isolated sacculi after 60 min treatment of cells
with antibiotics. From left to right columns, black panels are the control (SH1000), red panels are methicillin-treated SH1000, and blue panels are
vancomycin-treated SH1000. (i) In all of the columns, height channel of individual sacculi with the internal surface facing upwards, data scales (DS) = 202,
82, and 24 nm. In control, the zoomed image from the squared white area marked in i (ii), showing the internal coarse architecture displaying a smooth
surface, DS = 13 nm; in methicillin and vancomycin, internal coarse architecture displaying a surface perforated by some holes that span all the way on
the cell wall (ii), DS = 41 and 15 nm. In control, the zoomed image from the squared white area marked in ii (iii), showing the finer internal architecture,
which consists of a randomly oriented glycan fibrous mesh (see black arrows) with small pores between the fibers, DS = 12 nm; in methicillin and vanco-
mycin, randomly oriented glycan fibrous mesh (see white arrows) with small pores between the fibers next to some of the perforating holes (marked in
blue) (iii), DS = 10 and 16 nm. (B) The mean height of individual sacculi in air measured by AFM after 60 min treatment of antibiotics; error bars show SD;
for all samples, n = 28. After t test, P (control  methicillin, ****) = 2.364 × 1017, P (control  vancomycin, ****) = 5.323 × 1017, and P (methicillin 
vancomycin, **) = 4.816 × 103. (C) Binary images using the threshold technique (SI Appendix, Fig. S7) where white = PG, black = background, the black
areas inside the white sacculi correspond to holes spanning the cell wall. (i) Insets are the following: AFM topography images in which the binary image
analysis was performed; DS = 51, 92, and 104 nm. (D) Holes per surface area of sacculus (micrometer squared), sample size n = 3, 8, and 12 from left to
right; black lines represent mean value and SD. After t test with Welch's correction: p (control  methicillin, **) = 4.3 × 103, P (control  vancomycin,
**) = 1.5 × 103, and P (methicillin  vancomycin, not significant [ns]) = 0.65. (E) Cumulative fraction of total area plotting individual perforating holes:
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We have investigated bacterial growth and death due to antibi-
otics within the context of an overall framework of multiple
components responsible for PG synthesis and hydrolysis
(Fig. 1A). Growth requires the synthesis of new PG and its
subsequent hydrolysis. Here, we have separated these two
processes to establish their roles. WalKR positively regulates
multiple hydrolases (26), which together permit growth during
the exponential phase. The (initially counterintuitive) discovery
that bactericidal antibiotics prevent death of walKR-depleted
cells can be explained, as without WalKR, the cells have
reduced PGH but continued PG synthesis, resulting in death
due to thickened and aberrant cell walls coupled with an inabil-
ity to divide. The concomitant inhibition of PG synthesis
through the action of antibiotics results in stasis (Fig. 1A). This
explanation for cell growth establishes a clear hypothesis for
the bactericidal activity of cell wall antibiotics, in which the loss
of PG synthesis in the presence of PGHs would lead to cells
continuing growth-associated processing of PG until it can no
longer support turgor (SI Appendix, Fig. S11). The maturation
of synthesized material via PGHs occurs without a cell volume
increase per se, as the sagB mutant did not increase greatly in
volume but died, with holes appearing at the inside surface of
the cell wall.
Multiple PGHs with collective, essential roles in bacterial
growth and the bactericidal activity of antibiotics underline the
difficulties in identifying molecular mechanisms. This is com-
pounded by the different effects of methicillin and vancomycin
(SI Appendix, Fig. S11). In the presence of methicillin, those
PGHs involved in cell separation, including Atl, can cleave
incomplete septa, resulting in catastrophic failure, plasmolysis,
and cell death. However, vancomycin inhibits some PGH activ-
ity, including Atl, preventing early septal scission and the plas-
molysis observed with methicillin (SI Appendix, Fig. S11). Both
antibiotics kill S. aureus with the appearance of cell
wall–perforating holes, which involves the membrane-anchored
PGH, SagB. The model of cell wall antibiotic action is further
supported by the effect of complestatin, which, while showing
some bactericidal activity itself, significantly reduces the bacte-
ricidal activity of both methicillin and vancomycin by inhibiting
PGH in the absence of PG synthesis. This provides the final
permutation of the original model where loss of PG synthesis
or hydrolysis alone is lethal, but both is not (Fig. 1A). Here, we
have demonstrated a simple framework for understanding both
bacterial growth and the action of antibiotics in S. aureus, pro-
viding avenues for the development of control regimes for
important antimicrobial-resistant pathogens.
Materials and Methods
Bacterial Growth Conditions. Strains used in this study are listed in SI
Appendix, Table S1. Plasmids and oligonucleotides are listed in SI Appendix,
Tables S2 and S3, respectively. The construction of strains used in this study are
detailed in SI Appendix. All S. aureus strains were grown in tryptic soy broth
(TSB), Escherichia coli strains in lysogeny broth, and B. subtilis in nutrient broth
unless otherwise indicated, with appropriate antibiotics at 37 °C with agita-
tion. For solid media 1.5% weight/volume agar was added. Plasmids were
cloned using E. coli NEB-5α following previously described methods (50) and
directly electroporated into electrocompetent S. aureus RN4220. The transfor-
mation and phage transduction of S. aureus were carried out as described
previously (51, 52). Antibiotics were used at the following concentrations: van-
comycin (40 μg mL1), methicillin (40 μg mL1), oxacillin (10 μg mL1), ceru-
lenin (100 μg mL1), moenomycin (2 μg mL1), complestatin (100 μg mL1),
erythromycin (5 μg  mL1 for SH1000; 10 μg  mL1 for LAC*), tetracycline
(5 μg  mL1), kanamycin (50 μg  mL1 for SH1000; 90 μg  mL1 for LAC*),
spectinomycin (100 μg  mL1), and ampicillin (100 μg  mL1). Complestatin
was produced as previously described (40). Strains with genes under the con-
trol of the Pspac promoter were grown in the presence of IPTG at 10 μM or 1
mM as specified. azido D-alanine (ADA) and azido-D-alanyl-D-alanine;
Fig. 4. Differential role of PGH in the action of cell wall antibiotics. (A)
Deletion of atl and sagB increases S. aureus survival in the presence of spe-
cific antibiotics, 6 h treatment. After t test with Welch's correction, P (SH1000
+methicilin atl +methicillin, **) = 7.7 × 103, P (SH1000 +methicilin sagB
+ methicillin, ns) = 0.1930, P (atl + methicilin  SH1000 + vancomycin, ns) =
0.0737, P (SH1000 + vancomycin  atl + vancomycin, ns) = 0.1158, and P
(SH1000 + vancomycin sagB + vancomycin, *) = 0.0158. (B) Effect of methicil-
lin treatment (60 min) on cell volume as measured by SIM after NHS-ester Alex-
aFluor 555 labeling. After t test with Welch's correction, P (atl  atl + methicil-
lin, ****) = 2.305 × 1037, and P (sagB  sagB + methicillin, ****) = 7.685 ×
1017. (C) AFM images of purified sacculi are the following: top row, binary
threshold where white = PG, black = background (scale bars, 250 nm); bottom
row, height channel of internal sacculus architecture of sagB and atl mutants
after 10 × MIC methicillin or vancomycin treatment for 60 min (scale bars, 100
nm), data scale (DS) from left to right = 40, 40, and 30 nm. (D) Holes per sur-
face area (micrometer squared), sample size n = 8, 12, and 12 from left to right.
Black lines represent mean value and bars represent SD for strains treated with
antibiotics for 60 min. After t test with Welch's correction, P (atl  atl + methi-
cillin, **) = 1.349 × 103, P (sagB  sagB + methicillin, ***) = 1.753 × 104,
P (sagB  sagB þ vancomycin, *) = 1.546 × 102, and P (sagB þ methicillin 
sagB þ vancomycin, *) = 2.4 × 102, when compared to SH1000 strain:
P (SH1000 +methicillin atl +methicillin, ns) = 0.47, P (SH1000 +methicillin
sagB +methicillin, ns) = 0.57, and P (SH1000þ vancomycin sagBþ vancomy-
cin, *) = 1.24 × 102. (E) Cumulative fraction of total area plotting individual
perforating holes: atl, n = 408; sagB þ methicillin, n = 488; and sagB + vanco-
mycin, n = 122.
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dipeptide (ADA-DA) were produced as previously described and used at 500
mMor 1mM concentrations, respectively (53).
Antibiotic Activity Assays. S. aureus strains, apart from those containing
Pspac-walKR, were grown overnight in TSB. The overnight cultures were used
to inoculate fresh TSB media to an optical density at 600nm (OD600) of ∼0.05
and grown to anOD600 of 0.2 to 0.3. At this point, antibiotics were added, and
the change of bacterial count in the cultures was monitored. The CFU meas-
ures were normalized to the initial CFUs at the time of the antibiotic interven-
tion, time 0.




S. aureus Pspac-walKR strains were grown in TSB supplemented with tetracy-
cline and 1 mM IPTG overnight. Next, cells were washed in TSB and resus-
pended in fresh TSB supplemented with tetracycline and 10 μM IPTG to an
initial OD600 of 0.1. The cultures were grown to an OD600 of 0.5 and washed
three times in TSB. Cells were resuspended in fresh TSB supplemented with
tetracycline and incubated either with 1 mM IPTG (WalKR ON) or without
IPTG (WalKR OFF) in the presence or absence of cell wall antibiotics. The
change of bacterial count in the cultures was monitored. The CFU measures






There were at least three biological replicates of each assay.
Triton X-100–Induced Lysis. S. aureus strains were grown to midlog phase
(OD600 ∼0.4), washed by centrifugation, and resuspended in 0.1% volume/
volume Triton X-100 in phosphate-buffered saline to a final OD600 of ∼0.8,
with or without addition of antibiotics. Cell lysis was monitored by OD600
measurements.
Purification of PG Sacculi. PG was purified as described previously (54),
although some alterations were performed. Briefly, 1 L bacterial culture was
grown to an OD600 of 0.2 to 0.3 and then antibiotics were added as required.
A minimum of 200 mL of culture was used at each time point (e.g., 60 min).
Cell suspensions were boiled (10 min) and cells harvested by centrifugation
(5,000 g, 5 min, room temperature [RT]). The cells were mechanically broken
and sacculi purified (54).
Radioactive 14C-GlcNAc Incorporation. S. aureus strains were grown, and 1 mL
of cell culture was added to 2.5 μL of 14C-GlcNAc for a final concentration of
5 μM 14C-GlcNAc. The sample was incubated shaking at 37°C for 5 min,
collected, and prepared for analysis of 14C-GlcNAc incorporation via Liquid
Scintillation as previously described (55).
ADA or ADA-DA Labeling of PG. S. aureus cells were incubated with ADA or
dipeptide [produced as previously described (53)] on a rotary shaker at 37 °C
for 5 min. Cells were then fixed and labeled by Click chemistry. Dipeptide con-
taining an azide functional group required chemical attachment of a fluoro-
phore via the Click reaction (copper [I]-catalyzed alkyne-azide cycloaddition).
This was carried out using the Click-iT Cell Reaction Buffer Kit (Thermo Fisher)
as per the manufacturer’s protocol. Alkyne dyes were added at 5 mg/mL.
Microscopy Approaches. The study used a combination of fluorescence,
atomic force, transmission electron, and cryo-EM approaches throughout.
Methods and analyses and detailed in SI Appendix.
Ethics Statement. Animal work was completed in accordance with UK law
in the Animals (Scientific Procedures) Act 1986 under Project License
P3BFD6DB9 for murine experiments with approval of the Sheffield Ethical
Review Committee.
Murine Sepsis Infection. In all experiments, 6 to 8-wk-old female BALB/c mice
(Charles River Laboratories) were used. Mice were housed in designated ani-
mal facilities following standard husbandry protocols at the University of Shef-
field. Bacteria were prepared for murine injection (56), in which 100 mL of S.
aureus (1 × 107 CFU/mL) was injected intravenously into the tail vein of each
mouse, with 10 mice in each experimental group. Mice were monitored daily
(health and weight) and were euthanized at the experimental end point.
Organ CFU at the experimental endpoint was calculated (57) for livers and kid-
neys. For the analysis of methicillin and tarocin A1 in the murine sepsis model,
the NewHG (kanR) S. aureus strain was injected. At 21 and 25 hpi, mice were
subcutaneously injected with 100 μL containing either 1 mg tarocin A1
(SML1677-25MG, Sigma-Aldrich), 2.5 mg methicillin (51454-50mg, Sigma-
Aldrich), both tarocin A1 and methicillin, or a vehicle control, and mice were
euthanized at 48 h after infection.
Data Availability. All study data are included in the article and/or supporting
information. The data that support the findings of this study are available in
the Online Research Data figshare from the University of Sheffield with the
identifier DOI: 10.15131/shef.data.c.5656564.
ACKNOWLEDGMENTS. This research was funded in whole, or in part, by the
Wellcome Trust (Grant 212197/Z/19/Z). For the purpose of open access, the
authors have applied a CC BY public copyright license to any Author Accepted
Manuscript version arising from this submission. This work was also funded by
the Medical Research Council (grants MR/N002679/1; MR/R001111/1; MR/
S014934/1), UK Research and Innovation Strategic Priorities Fund (Grant
EP/T002778/1), and the National Science Foundation of China (Grant
81861138047). L.P.-L. and L.L. thank The Florey Institute for their studentships,
L.K. thanks the China Scholarship Council and British Council (Newton fund,
PhD placement), andM.v.M. thanks the Biotechnology and Biological Sciences
Research Council for her studentship. We are grateful to Oliver Carnell, Grace
Pidwill, Irene Johnson, and Chris Hill for help and advice.
1. A. L. Koch, Growth and form of the bacterial cell wall.Am. Sci. 78, 327–341 (1990).
2. A. K. Yadav, A. Espaillat, F. Cava, Bacterial strategies to preserve cell wall integrity
against environmental threats. Front. Microbiol. 9, 2064 (2018).
3. T. D€orr, P. J. Moynihan, C. Mayer, Editorial: Bacterial cell wall structure and dynamics.
Front. Microbiol. 10, 2051 (2019).
4. R. D. Turner, W. Vollmer, S. J. Foster, Different walls for rods and balls: The diversity
of peptidoglycan.Mol. Microbiol. 91, 862–874 (2014).
5. W. Vollmer, D. Blanot, M. A. de Pedro, Peptidoglycan structure and architecture.
FEMSMicrobiol. Rev. 32, 149–167 (2008).
6. T. Schneider, H. G. Sahl, An oldie but a goodie—Cell wall biosynthesis as antibiotic
target pathway. Int. J. Med.Microbiol. 300, 161–169 (2010).
7. H. Cho, T. Uehara, T. G. Bernhardt, Beta-lactam antibiotics induce a lethal malfunc-
tioning of the bacterial cell wall synthesis machinery. Cell 159, 1300–1311 (2014).
8. P. Giesbrecht, T. Kersten, H.Maidhof, J. Wecke, Staphylococcal cell wall: Morphogen-
esis and fatal variations in the presence of penicillin. Microbiol. Mol. Biol. Rev. 62,
1371–1414 (1998).
9. Y. Kawai et al., Crucial role for central carbon metabolism in the bacterial L-form
switch and killing by β-lactam antibiotics.Nat.Microbiol. 4, 1716–1726 (2019).
10. M. A. Kohanski, D. J. Dwyer, B. Hayete, C. A. Lawrence, J. J. Collins, A commonmecha-
nism of cellular death induced by bactericidal antibiotics. Cell 130, 797–810 (2007).
11. A. Tomasz, Themechanismof the irreversible antimicrobial effects of penicillins: How the
beta-lactamantibiotics kill and lyse bacteria.Annu. Rev.Microbiol. 33, 113–137 (1979).
12. A. Tomasz, A. Albino, E. Zanati, Multiple antibiotic resistance in a bacterium with
suppressed autolytic system.Nature 227, 138–140 (1970).
13. T. K. Lee, K. C. Huang, The role of hydrolases in bacterial cell-wall growth. Curr. Opin.
Microbiol. 16, 760–766 (2013).
14. W. Vollmer, B. Joris, P. Charlier, S. Foster, Bacterial peptidoglycan (murein) hydro-
lases. FEMSMicrobiol. Rev. 32, 259–286 (2008).
15. C. Goffin, J. M. Ghuysen, Multimodular penicillin-binding proteins: An enigmatic
family of orthologs and paralogs.Microbiol. Mol. Biol. Rev. 62, 1079–1093 (1998).
16. A. Wada, H. Watanabe, Penicillin-binding protein 1 of Staphylococcus aureus is
essential for growth. J. Bacteriol. 180, 2759–2765 (1998).
17. S. F. Pereira, A. O. Henriques, M. G. Pinho, H. de Lencastre, A. Tomasz, Role of PBP1 in
cell division of Staphylococcus aureus. J. Bacteriol. 189, 3525–3531 (2007).
18. S. F. Pereira, A. O. Henriques, M. G. Pinho, H. de Lencastre, A. Tomasz, Evidence for a
dual role of PBP1 in the cell division and cell separation of Staphylococcus aureus.
Mol. Microbiol. 72, 895–904 (2009).
19. M. G. Pinho, S. R. Filipe, H. de Lencastre, A. Tomasz, Complementation of the
essential peptidoglycan transpeptidase function of penicillin-binding protein 2
(PBP2) by the drug resistance protein PBP2A in Staphylococcus aureus. J. Bacteriol.
183, 6525–6531 (2001).
20. R. Wheeler et al., Bacterial cell enlargement requires control of cell wall stiffness
mediated by peptidoglycan hydrolases.MBio 6, e00660 (2015).
21. Y. G. Chan, M. B. Frankel, D. Missiakas, O. Schneewind, SagB glucosaminidase is a
determinant of staphylococcus aureus glycan chain length, antibiotic susceptibility,
and protein secretion. J. Bacteriol. 198, 1123–1136 (2016).
22. S. J. Foster, Molecular characterization and functional analysis of the major autolysin
of Staphylococcus aureus 8325/4. J. Bacteriol. 177, 5723–5725 (1995).
23. T. Oshida et al., A Staphylococcus aureus autolysin that has an N-acetylmuramoyl-L-
alanine amidase domain and an endo-beta-N-acetylglucosaminidase domain: Clon-












Demonstration of the role of cell wall homeostasis in Staphylococcus aureus growth and
the action of bactericidal antibiotics



































24. J. Kajimura et al., Identification and molecular characterization of an N-acetylmur-
amyl-L-alanine amidase Sle1 involved in cell separation of Staphylococcus aureus.
Mol. Microbiol. 58, 1087–1101 (2005).
25. A. Delaune et al., The WalKR system controls major staphylococcal virulence genes
and is involved in triggering the host inflammatory response. Infect. Immun. 80,
3438–3453 (2012).
26. A. Delaune et al., Peptidoglycan crosslinking relaxation plays an important role in
Staphylococcus aureusWalKR-dependent cell viability. PLoS One 6, e17054 (2011).
27. S. Dubrac, P. Bisicchia, K. M. Devine, T. Msadek, A matter of life and death: Cell wall
homeostasis and the WalKR (YycGF) essential signal transduction pathway. Mol.
Microbiol. 70, 1307–1322 (2008).
28. L. Pasquina-Lemonche et al., The architecture of the Gram-positive bacterial cell wall.
Nature 582, 294–297 (2020).
29. M. B. Frankel, A. P. Hendrickx, D. M. Missiakas, O. Schneewind, LytN, a murein hydro-
lase in the cross-wall compartment of Staphylococcus aureus, is involved in proper
bacterial growth and envelope assembly. J. Biol. Chem. 286, 32593–32605 (2011).
30. M. R. Stapleton et al., Characterization of IsaA and SceD, two putative lytic transgly-
cosylases of Staphylococcus aureus. J. Bacteriol. 189, 7316–7325 (2007).
31. L. Zheng, M. Yan, F. Fan, Y. Ji, The essential WalK histidine kinase andWalR regulator
differentially mediate autolysis of Staphylococcus aureus RN4220. J. Nat. Sci. 1, e111
(2015).
32. S. Dubrac, T. Msadek, Identification of genes controlled by the essential YycG/YycF
two-component systemof Staphylococcus aureus. J. Bacteriol. 186, 1175–1181 (2004).
33. R. P. Adhikari, R. P. Novick, Subinhibitory cerulenin inhibits staphylococcal exopro-
tein production by blocking transcription rather than by blocking secretion.Microbi-
ology (Reading) 151, 3059–3069 (2005).
34. Y. Rebets et al., Moenomycin resistance mutations in Staphylococcus aureus reduce
peptidoglycan chain length and cause aberrant cell division. ACS Chem. Biol. 9,
459–467 (2014).
35. C. Weidenmaier et al., Lack of wall teichoic acids in Staphylococcus aureus leads to
reduced interactions with endothelial cells and to attenuated virulence in a rabbit
model of endocarditis. J. Infect. Dis. 191, 1771–1777 (2005).
36. R. M. Corrigan, J. C. Abbott, H. Burhenne, V. Kaever, A. Gr€undling, c-di-AMP is a new
second messenger in Staphylococcus aureus with a role in controlling cell size and
envelope stress. PLoS Pathog. 7, e1002217 (2011).
37. E. S. Duthie, L. L. Lorenz, Staphylococcal coagulase; mode of action and antigenicity.
J. Gen.Microbiol. 6, 95–107 (1952).
38. W. M. Shafer, J. J. Iandolo, Genetics of staphylococcal enterotoxin B in methicillin-
resistant isolates of Staphylococcus aureus. Infect. Immun. 25, 902–911 (1979).
39. T. J. Smith, S. A. Blackman, S. J. Foster, Autolysins of Bacillus subtilis: Multiple
enzymeswithmultiple functions.Microbiology (Reading) 146, 249–262 (2000).
40. E. J. Culp et al., Evolution-guided discovery of antibiotics that inhibit peptidoglycan
remodelling.Nature 578, 582–587 (2020).
41. R. Biswas et al., Activity of the major staphylococcal autolysin Atl. FEMS Microbiol.
Lett. 259, 260–268 (2006).
42. J. Eirich, R. Orth, S. A. Sieber, Unraveling the protein targets of vancomycin in living
S. aureus and E. faecalis cells. J. Am. Chem. Soc. 133, 12144–12153 (2011).
43. C. Weidenmaier et al., Role of teichoic acids in Staphylococcus aureus nasal colo-
nization, a major risk factor in nosocomial infections. Nat. Med. 10, 243–245
(2004).
44. M. Schlag et al., Role of staphylococcal wall teichoic acid in targeting themajor auto-
lysin Atl.Mol. Microbiol. 75, 864–873 (2010).
45. R. Biswas et al., Proton-binding capacity of Staphylococcus aureus wall teichoic acid
and its role in controlling autolysin activity. PLoS One 7, e41415 (2012).
46. B. Gollan, G. Grabe, C. Michaux, S. Helaine, Bacterial persisters and infection: Past,
present, and progressing.Annu. Rev.Microbiol. 73, 359–385 (2019).
47. J. Campbell et al., Synthetic lethal compound combinations reveal a fundamental
connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylo-
coccus aureus. ACS Chem. Biol. 6, 106–116 (2011).
48. M. A. Farha et al., Inhibition of WTA synthesis blocks the cooperative action of PBPs
and sensitizesMRSA to β-lactams.ACS Chem. Biol. 8, 226–233 (2013).
49. S. H. Lee et al., TarO-specific inhibitors of wall teichoic acid biosynthesis restore
β-lactam efficacy against methicillin-resistant staphylococci. Sci. Transl. Med. 8,
329ra32 (2016).
50. J. Sambrook, E. F. Fritsch, T. Maniatis,Molecular Cloning: A Laboratory Manual (Cold
Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989).
51. R. P. Novick, S. I. Morse, In vivo transmission of drug resistance factors between
strains of Staphylococcus aureus. J. Exp.Med. 125, 45–59 (1967).
52. S. Schenk, R. A. Laddaga, Improved method for electroporation of Staphylococcus
aureus. FEMSMicrobiol. Lett. 73, 133–138 (1992).
53. V. A. Lund et al., Molecular coordination of Staphylococcus aureus cell division. eLife
7, e32057 (2018).
54. R. D. Turner, J. K. Hobbs, S. J. Foster, Atomic force microscopy analysis of bacterial cell
wall peptidoglycan architecture.MethodsMol. Biol. 1440, 3–9 (2016).
55. H. Maki, K. Miura, Y. Yamano, Katanosin B and plusbacin A(3), inhibitors of peptido-
glycan synthesis in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents
Chemother. 45, 1823–1827 (2001).
56. V. V. Panchal et al., Evolving MRSA: High-level β-lactam resistance in Staphylococcus
aureus is associatedwith RNA Polymerase alterations andfine tuning of gene expres-
sion. PLoS Pathog. 16, e1008672 (2020).
57. E. Boldock et al., Human skin commensals augment Staphylococcus aureus patho-
genesis.Nat. Microbiol. 3, 881–890 (2018).
8 of 8 j PNAS Salamaga et al.
https://doi.org/10.1073/pnas.2106022118 Demonstration of the role of cell wall homeostasis in Staphylococcus aureus growth and
the action of bactericidal antibiotics
D
o
w
n
lo
a
d
e
d
 b
y
 g
u
e
s
t 
o
n
 N
o
v
e
m
b
e
r 
8
, 
2
0
2
1
 
